Skip to content
2000
Volume 8, Issue 3
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Attempts have been made to find specific antigens for a novel NKT cell subset bearing invariant Vα19-Jα33 TCR α chains (Vα19 NKT cell). Comprehensive examinations revealed substantial antigenic activity in synthetic α- mannosylceramide (ManCer) that was presented by MR1. Structural modification of the sphingosine moiety of α-ManCer improved antigenic activity to enhance either Th1 or Th2 -promoting cytokine production by Vα19 NKT cells. Such α- ManCer analogues will be useful for developing new therapies as immunomodulators.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955708783744119
2008-03-01
2025-09-07
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955708783744119
Loading

  • Article Type:
    Research Article
Keyword(s): FTY720; Glycolipid; immunomodulator; invariant TCR; NKT cell; non-classical MHC class I
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test